Top-News
Mittwoch,
23.09.2015 13:35
von
PR Newswire
| Aufrufe: 91
Hynes Keller & Hernandez, LLC Announces Investigations of AAC Holdings, Inc., Muscle Pharm Corp., and Hill International, Inc.
Ein Verkaufsgespräch (Symbolbild).
pixabay.com
PR Newswire
NEW YORK, Sept. 23, 2015
NEW YORK, Sept. 23, 2015 /PRNewswire/ -- Hynes Keller & Hernandez, LLC is investigating potential claims against AAC Holdings, Inc., Hill International, Inc. and Muscle Pharm Corp. as detailed below.
AAC Holdings, Inc. ("AAC")
Hynes Keller & Hernandez, LLC is investigating potential claims against the Board of Directors of AAC (NYSE: AAC) arising from the indictment of AAC's CEO and certain other employees on murder charges relating to the death of an AAC patient in 2010.
Click here for more information about AAC: http://hkh-lawfirm.com/investigations-cases/aac-holdings-inc-aac/
Muscle Pharm Corp ("Muscle Pharm")
Hynes Keller & Hernandez, LLC is investigating potential claims against the Board of Directors of Muscle Pharm Corp. (OTCQB: MSLP) concerning possible breaches of fiduciary duty arising from, among other things, an SEC investigation into certain disclosure and internal control deficiencies, including executive perquisites and related-party transactions, at Muscle Pharm between 2010 and 2013.
Click here for more information about Muscle Pharm: http://hkh-lawfirm.com/investigations-cases/muscle-pharm-corp-mslp/
Hill International, Inc. ("Hill")
Hynes Keller & Hernandez, LLC is investigating potential claims against the Board of Directors at Hill (NYSE: HIL) concerning possible breaches of fiduciary duty arising from Hill's entry into a $120 million term loan facility and a $30 million revolving credit facility.
Click here for more information about Hill: http://hkh-lawfirm.com/investigations-cases/hill-international-inc-hil/
Hynes Keller & Hernandez, LLC is a national law firm that represents institutional and individual investors. The firm is focused on providing exemplary legal services in the area of shareholder litigation. The firm has an experienced litigation team which has achieved significant victories on behalf of the firm's clients. You can visit our website at www.hkh-lawfirm.com for more information. Attorney advertising. Prior results do not guarantee similar outcomes.
If you hold shares in AAC, MSLP or HIL and would like to obtain additional information about your legal rights and protect your investment, please visit our website or contact the attorneys below. There is no cost or obligation to you.
| Contact: | |
| | |
| Hynes Keller & Hernandez, LLC | Hynes Keller & Hernandez, LLC |
| Ligaya T. Hernandez, Esq. | Beth A. Keller, Esq. |
| 1150 First Avenue, Suite 501 | 100 South Bedford Road, Suite 340 |
| King of Prussia, PA 19406 | Mount Kisco, NY 10549 |
| Telephone: (610) 994-0292 | Telephone: (914) 752-3040 |
| Email: lhernandez@hkh-lawfirm.com | Email: bkeller@hkh-lawfirm.com |
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/hynes-keller--hernandez-llc-announces-investigations-of-aac-holdings-inc-muscle-pharm-corp-and-hill-international-inc-300147645.html
SOURCE Hynes Keller & Hernandez, LLC
Werbung
Mehr Nachrichten zur Hill International Aktie kostenlos abonnieren
E-Mail-Adresse
Bitte überprüfe deine die E-Mail-Adresse.
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)
-1
Vielen Dank, dass du dich für unseren Newsletter angemeldet hast. Du erhältst in Kürze eine E-Mail mit einem Aktivierungslink.
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.
